vs

Side-by-side financial comparison of GoPro, Inc. (GPRO) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $201.7M, roughly 1.1× GoPro, Inc.). On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 0.4%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $15.0M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 13.9%).

GoPro, Inc. is an American technology company founded in 2002 by Nick Woodman. It manufactures action cameras and develops its own mobile apps and video-editing software. Founded as Woodman Labs, Inc, the company is based in San Mateo, California.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

GPRO vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.1× larger
ORGO
$225.6M
$201.7M
GPRO
Growing faster (revenue YoY)
ORGO
ORGO
+77.7% gap
ORGO
78.1%
0.4%
GPRO
More free cash flow
ORGO
ORGO
$19.8M more FCF
ORGO
$34.8M
$15.0M
GPRO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
13.9%
GPRO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GPRO
GPRO
ORGO
ORGO
Revenue
$201.7M
$225.6M
Net Profit
$43.7M
Gross Margin
31.8%
Operating Margin
-4.1%
28.1%
Net Margin
19.4%
Revenue YoY
0.4%
78.1%
Net Profit YoY
469.5%
EPS (diluted)
$-0.06
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GPRO
GPRO
ORGO
ORGO
Q4 25
$201.7M
$225.6M
Q3 25
$162.9M
$150.9M
Q2 25
$152.6M
$101.0M
Q1 25
$134.3M
$86.7M
Q4 24
$200.9M
$126.7M
Q3 24
$258.9M
$115.2M
Q2 24
$186.2M
$130.2M
Q1 24
$155.5M
$110.0M
Net Profit
GPRO
GPRO
ORGO
ORGO
Q4 25
$43.7M
Q3 25
$-21.3M
$21.6M
Q2 25
$-16.4M
$-9.4M
Q1 25
$-46.7M
$-18.8M
Q4 24
$7.7M
Q3 24
$-8.2M
$12.3M
Q2 24
$-47.8M
$-17.0M
Q1 24
$-339.1M
$-2.1M
Gross Margin
GPRO
GPRO
ORGO
ORGO
Q4 25
31.8%
Q3 25
35.1%
Q2 25
35.8%
Q1 25
32.1%
72.6%
Q4 24
34.7%
75.5%
Q3 24
35.5%
76.7%
Q2 24
30.5%
77.6%
Q1 24
34.1%
73.9%
Operating Margin
GPRO
GPRO
ORGO
ORGO
Q4 25
-4.1%
28.1%
Q3 25
-9.8%
13.7%
Q2 25
-9.2%
-12.5%
Q1 25
-33.7%
-30.9%
Q4 24
-19.5%
8.1%
Q3 24
-3.1%
5.4%
Q2 24
-25.0%
-10.7%
Q1 24
-26.6%
-3.5%
Net Margin
GPRO
GPRO
ORGO
ORGO
Q4 25
19.4%
Q3 25
-13.0%
14.3%
Q2 25
-10.8%
-9.3%
Q1 25
-34.8%
-21.7%
Q4 24
6.1%
Q3 24
-3.2%
10.7%
Q2 24
-25.7%
-13.1%
Q1 24
-218.1%
-1.9%
EPS (diluted)
GPRO
GPRO
ORGO
ORGO
Q4 25
$-0.06
$0.31
Q3 25
$-0.13
$0.11
Q2 25
$-0.10
$-0.10
Q1 25
$-0.30
$-0.17
Q4 24
$-0.22
$0.05
Q3 24
$-0.05
$0.09
Q2 24
$-0.31
$-0.13
Q1 24
$-2.24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GPRO
GPRO
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$49.7M
$93.7M
Total DebtLower is stronger
$44.3M
Stockholders' EquityBook value
$76.5M
$300.1M
Total Assets
$428.0M
$598.7M
Debt / EquityLower = less leverage
0.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GPRO
GPRO
ORGO
ORGO
Q4 25
$49.7M
$93.7M
Q3 25
$152.8M
$63.7M
Q2 25
$58.6M
$73.1M
Q1 25
$69.6M
$110.0M
Q4 24
$102.8M
$135.6M
Q3 24
$130.2M
$94.3M
Q2 24
$133.0M
$89.9M
Q1 24
$133.7M
$88.6M
Total Debt
GPRO
GPRO
ORGO
ORGO
Q4 25
$44.3M
Q3 25
$43.9M
Q2 25
Q1 25
Q4 24
$0
Q3 24
$93.1M
$62.3M
Q2 24
$92.9M
$63.8M
Q1 24
$92.7M
$65.2M
Stockholders' Equity
GPRO
GPRO
ORGO
ORGO
Q4 25
$76.5M
$300.1M
Q3 25
$80.5M
$255.1M
Q2 25
$97.9M
$233.2M
Q1 25
$110.0M
$242.9M
Q4 24
$151.7M
$262.9M
Q3 24
$183.9M
$278.5M
Q2 24
$184.7M
$263.5M
Q1 24
$224.9M
$278.0M
Total Assets
GPRO
GPRO
ORGO
ORGO
Q4 25
$428.0M
$598.7M
Q3 25
$538.6M
$509.8M
Q2 25
$439.0M
$461.1M
Q1 25
$462.5M
$467.4M
Q4 24
$543.7M
$497.9M
Q3 24
$661.6M
$446.3M
Q2 24
$556.8M
$443.2M
Q1 24
$575.8M
$458.5M
Debt / Equity
GPRO
GPRO
ORGO
ORGO
Q4 25
0.58×
Q3 25
0.55×
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.51×
0.22×
Q2 24
0.50×
0.24×
Q1 24
0.41×
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GPRO
GPRO
ORGO
ORGO
Operating Cash FlowLast quarter
$15.6M
$39.4M
Free Cash FlowOCF − Capex
$15.0M
$34.8M
FCF MarginFCF / Revenue
7.4%
15.4%
Capex IntensityCapex / Revenue
0.3%
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.0M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GPRO
GPRO
ORGO
ORGO
Q4 25
$15.6M
$39.4M
Q3 25
$12.2M
$3.1M
Q2 25
$8.8M
$-32.9M
Q1 25
$-57.2M
$-19.9M
Q4 24
$-25.1M
$10.9M
Q3 24
$-2.2M
$8.7M
Q2 24
$605.0K
$4.7M
Q1 24
$-98.4M
$-10.2M
Free Cash Flow
GPRO
GPRO
ORGO
ORGO
Q4 25
$15.0M
$34.8M
Q3 25
$11.2M
$844.0K
Q2 25
$8.3M
$-36.5M
Q1 25
$-58.5M
$-23.6M
Q4 24
$-25.5M
$7.6M
Q3 24
$-4.2M
$6.1M
Q2 24
$-111.0K
$2.9M
Q1 24
$-99.4M
$-12.4M
FCF Margin
GPRO
GPRO
ORGO
ORGO
Q4 25
7.4%
15.4%
Q3 25
6.9%
0.6%
Q2 25
5.4%
-36.1%
Q1 25
-43.5%
-27.2%
Q4 24
-12.7%
6.0%
Q3 24
-1.6%
5.3%
Q2 24
-0.1%
2.2%
Q1 24
-63.9%
-11.3%
Capex Intensity
GPRO
GPRO
ORGO
ORGO
Q4 25
0.3%
2.1%
Q3 25
0.6%
1.5%
Q2 25
0.3%
3.6%
Q1 25
1.0%
4.2%
Q4 24
0.2%
2.7%
Q3 24
0.8%
2.2%
Q2 24
0.4%
1.4%
Q1 24
0.6%
2.0%
Cash Conversion
GPRO
GPRO
ORGO
ORGO
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GPRO
GPRO

Subscription And Services$106.3M53%
Other$95.4M47%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons